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Abstract
Background—For patients with cancer who are married or in an intimate relationship, their
relationships with their partners play a critical role in their adaptation to their illness. However,
cancer patients and their partners often have difficulty in talking with each other about their
cancer-related concerns. Difficulties in communication may ultimately compromise both the
patient-partner relationship and the patient's psychological adjustment. The present study tested
the efficacy of a novel partner-assisted emotional disclosure intervention in a sample of patients
with gastrointestinal (GI) cancer.
Methods—130 patients with GI cancer and their partners were randomly assigned to receive four
sessions of either partner-assisted emotional disclosure or a couples cancer education/support
intervention. Patients and partners completed measures of relationship quality, intimacy with their
partner, and psychological distress before randomization and at the end of the intervention
sessions. Data were analyzed using multilevel modeling.
Results—Compared to an education/support condition, the partner-assisted emotional disclosure
condition led to improvements in relationship quality and intimacy for couples in which the
patient initially reported higher levels of holding back from discussing cancer-related concerns.
Conclusions—Partner-assisted emotional disclosure is a novel intervention that builds on both
the private emotional disclosure and the cognitive-behavioral marital literature. The results of this
study suggest that this intervention may be beneficial for couples in which the patient tends to
hold back from discussing concerns. Future research on methods of enhancing the effects of
partner-assisted emotional disclosure is warranted.
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For patients with cancer who are married or in an intimate relationship, the relationship with
their partner plays a critical role in adapting to their illness.1–3 Both patients and partners
often perceive social support and family functioning to diminish in the year following a
cancer diagnosis,3–5 suggesting that some couples may be at risk of relationship distress as
a result of the burdens imposed by the cancer experience. One factor that may lead to
deteriorations in patient-partner relationships is the challenge of communicating effectively
The authors thank Susan Elinoff, Laura Harris, M.S.W., Regina Ragan, M.S.W., Rebecca Shelby, Ph.D., Catherine Moser, Ph.D.,
Johanna Bendell, M.D., Leigh Howard, R.N., and the physicians and staff of the Duke GI Oncology clinic for their assistance. They
also extend their gratitude to all of the study participants for their time and effort.
NIH Public Access
Author Manuscript
Cancer. Author manuscript; available in PMC 2010 September 15.
Published in final edited form as:













about cancer-related concerns. Married cancer patients tend to rate their spouses as their
most important confidant,6, 7 however, cancer patients often feel constrained in talking
about their concerns with their partners, and partners often withdraw or distance themselves
from the patient's emotional distress.2, 6, 8–10 These avoidant patterns are present even in
even in relationships that are satisfying.11
Patients' inability to talk openly with their partners about their cancer-related concerns may
ultimately compromise the quality of the patient-partner relationship as well as the patient's
psychological adjustment Emotional disclosure – defined as the expression of information
that is personal, private, and emotional in nature12 – is a central component of the emotional
support (e.g. love, concern, and understanding) that partners provide to each other.13, 14
The construct of emotional disclosure has been operationalized as both (a) the degree to
which individuals express their thoughts and feelings, and (b) the degree to which they hold
back from doing so. While expression and holding back may be seen as opposites of each
other, they are in fact only moderately negatively correlated (e.g., −.3215 to −.3816),
suggesting that they may represent orthogonal constructs. Holding back may reflect active
inhibition of expression rather than a general tendency towards inexpression. Prior studies
suggest that high levels of holding back, more so than low levels of expression, are
significantly associated with poorer relationship functioning and increased psychological
distress.16, 7 To date, however, all of the studies in this area have been correlational, thus it
is not possible to draw causal conclusions about the effects of disclosure or holding back.
A number of studies, including several studies conducted with cancer patients,17–20 have
shown that expressive writing protocols can produce improvements in psychological and
physical well-being (e.g., improved affect, decreased psychological distress and self-
reported symptoms).21, 22 In these protocols, participants typically write for 15–20 minutes
over several sessions about their deepest thoughts and feelings regarding stressful
experiences. In this paradigm, disclosure is private and anonymous; participants are alone
when they disclose and their disclosures are not shared with anyone other than the
researchers. When applied to patients with cancer, this intervention has been found to lead to
improved sleep and vigor in patients with metastatic renal cell cancer17 and to significant
reductions in physical symptoms and medical appointments among patients with breast
cancer.18
In a separate tradition, increasing emotional disclosure between spouses is often a focus of
cognitive-behavioral couple therapy23, 24 A large body of empirical literature demonstrates
that in a variety of settings, cognitive-behavioral interventions for couples can significantly
improve both individual adjustment and relationship functioning.25 Cognitive-behavioral
couple interventions focus specifically on learning relationship skills such as
communication. Increases in emotional disclosure that occur during the course of cognitive-
behavioral couples therapy have been linked to enhanced intimacy and marital satisfaction.
26 However, to our knowledge, the potential benefits of facilitating disclosure regarding
cancer-related issues between cancer patients and their partners have not been addressed.
There are several reasons why increasing emotional disclosure between cancer patients and
their partners is likely to lead to benefits for couples' relationships. First, as noted above,
increasing emotional disclosure may lead to increases in intimacy and relationship
satisfaction.27 Second, helping couples to discuss their cancer-related concerns may help
partners have a better understanding of patients' needs, and to provide more effective
support. In addition, it is possible that patients may derive the same individual psychological
benefits from disclosure to their partner as they do from private emotional disclosure
protocols. Finally, partners may benefit from hearing the patients talk openly about their
concerns. Often a partner senses when the patient has concerns and is not expressing them,
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and this can lead to increase distress for the partner; when the patient shares his/her
concerns, the partner may experience this as a relief.
The purpose of this study was to evaluate the efficacy of a new partner-assisted emotional
disclosure protocol for patients with GI cancer. GI cancers make a particularly good model
in which to study the effects of this protocol for several reasons. First, they are common,
with colorectal cancers being the third leading site of cancer occurrence and cancer mortality
for both men and women. 28 Second, they are often discovered at advanced stages when the
prognosis for survival is poor. 28, 29 While treatments have been shown to improve
survival, tumor control, and quality of life due to relief of tumor-related symptoms, these
treatments are often associated with significant toxicities. Patients report multiple disease
and treatment-related side effects including fatigue, pain, difficulty eating, weight loss,
problems with bowel function, and sexual problems.29–32 Many patients also experience
significant emotional distress including disturbances in body image, anxiety and worry,
depression, and fears of disease progression and death.3, 29–32 Thus, the diagnosis and
treatment of GI cancer poses numerous physical and psychological challenges for patients as
well as their loved ones.
The partner-assisted emotional disclosure intervention was designed to systematically train
patients and partners in strategies to facilitate the patients' disclosure and give the patient the
opportunity to talk about their cancer-related concerns to their partner. We hypothesized that
the intervention would lead to improvements in relationship quality, intimacy, and
psychological distress for patients and their partners relative to an attention control
condition. In addition, we conducted exploratory analyses examining whether intervention
effects differed by gender or by the degree to which patients reported holding back from
disclosing cancer-related concerns to their spouse at baseline.
Method
Participants
Eligible participants were (a) individuals diagnosed with GI cancer, Stages 2–4, with a life
expectancy of at least 6 months, and (b) their spouses or intimate partners. Patients were
recruited from the GI oncology clinics at Duke University and University of North Carolina
Hospitals. This study was approved by the Institutional Review Boards at Duke University
Medical Center and University of North Carolina School of Medicine, and informed consent
was obtained from all participants.
A total of 603 patients were screened for the study, deemed eligible, and approached
regarding participation (for CONSORT diagram see Figure 1). Of these patients, 150 (25%)
expressed willingness to participate and their partners also agreed to take part. The most
common reasons for refusal were that the patient lived at a distance from the medical center
and was not willing to travel for the sessions (n=112), the patient and/or partner were not
interested (n=95) or felt the study would be too time-consuming (n=24), and that the patient
was too ill to participate (n=18).
Of the 150 patients who consented, 20 withdrew prior to randomization. Reasons for
withdrawal included death/declining health (n=9), lack of time (n=6), distance (n=3), and
lost to contact (n=2). This resulted in 130 couples who were included in the current analyses.
Procedures
After completing informed consent, participants in the study were administered pretreatment
measures and were then randomly assigned to one of the two conditions: Partner-Assisted
emotional disclosure or Education/Support. The treatment conditions are described below.
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Randomization was stratified by patient sex and cancer stage (2 and 3 versus 4). After
completing the intervention, participants in both conditions completed post-treatment
measures. All evaluations were completed by telephone interviews conducted by a research
assistant who was blind to the participant's treatment condition. Each participant (patient and
partner) was reimbursed $40 ($20 for each of the two evaluations).
Measures
The following measures were completed by both patients and partners:
Relationship quality was assessed using the Quality of Marriage Index (QMI).33 The QMI
is a 6-item inventory that assesses relationship satisfaction using broadly worded, global
items. Participants indicate whether they agree with each item on a 0–10 scale where 0
means “very strongly disagree” and 10 means “very strongly agree”. Sample items include
“My relationship with my partner makes me happy” and “I really feel like part of a team
with my partner.” The QMI has demonstrated good reliability and validity, correlating
highly with longer, well-validated measures of marital adjustment such as the Dyadic
Adjustment Scale.33, 34 Cronbach's alpha in the current study was .92 for patients and .89
for partners.
Intimacy with the partner was assessed using the Miller Social Intimacy Scale (MSIS).35
The MSIS is a 17 item self-report inventory that assesses the degree of intimacy, closeness,
and trust that an individual feels in a relationship toward his or her partner. Sample items
include “How close do you feel to your partner most of the time?” and “When you have
leisure time, how often do you choose to spend it with your partner alone?” There is good
evidence that the measure discriminates close from casual friends and happily married from
distressed couples, and the MSIS can detect clinically meaningful change following
psychological treatment.35, 36 Cronbach's alpha in the current study was .92 for patients
and .88 for partners.
Psychological distress was assessed using the Profile of Mood States-Short Form (POMS-
SF).37 This measure asks participants to describe their mood over the past week by rating
each of thirty adjectives on a scale from 0=very much unlike this to 3=very much like this.
There are six subscales (anxiety, depression, anger, vigor, fatigue, and confusion), as well as
a Total Mood Disturbance (TMD) scale. The POMS has good temporal stability, excellent
internal consistency, and good convergent validity with other measures of psychological
distress. The POMS is often used in cancer research studies and has been found to be
sensitive to improvements following psychological interventions in cancer patients.38, 39 In
the current study, Cronbach's alphas for the subscales ranged from .74 to .93 for both
patients and partners; Cronbach's alpha for the TMD was .88 for patients and .90 for
partners.
Holding back—Holding back from disclosure of cancer-related thoughts and feelings was
assessed using a modified version of a measure developed by Pistrang and Barker.15 The
measure consists of ten items that assess the extent to which patients talk about their cancer-
related feelings and concerns to their spouse, and how much they hold back from doing so
on a scale of 0 (“not at all”) to 5 (“a lot”). Only the holding back scale was used in the
current study. In previous studies of patients with GI cancer16 and breast cancer7, 15, high
levels of holding back were significantly associated with increased psychological distress
and poorer relationship functioning. Cronbach's alpha in the current study was .88.
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Partner-Assisted Emotional Disclosure Intervention
The partner-assisted emotional disclosure (emotional disclosure) protocol was designed to
train couples systematically in skills designed to help patients disclose their feelings and
concerns related to the cancer experience. Couples attended four face-to-face sessions with a
master's level therapist (social worker or psychologist). The first session lasted
approximately 75 minutes and Sessions 2–4 lasted 45 minutes each. Whereas it was
intended that sessions be scheduled weekly, couples were given up to eight weeks to
complete the four sessions in order to accommodate delays due to the patient's medical
condition and/or to coordinate sessions with other appointments at the medical center. In the
first session, the therapist provided a rationale for the intervention and trained the couple in
skills designed to help the patient disclose his/her concerns related to the cancer experience.
Patients' guidelines for disclosure including (a) thinking about an experience related to
having cancer that caused strong emotions; (b) telling their partner about the experience in
as much detail as possible, including both the events and feelings related to the experience;
and (c) pausing periodically to give their partner the opportunity to respond (e.g., talking in
paragraphs). The partners' role was that of supporter. Their guidelines included (a) trying to
put themselves in the patient's place and understand what the experience was like for him/
her; (b) avoiding problem-solving, reassurance, or advice giving; and (c) reflective listening
(e.g., summarizing what the patient said). Training included both didactic and experiential
components and was summarized in handouts given to the couples.The therapist helped the
couple identify partner responses that the patient found helpful and unhelpful and assisted
patients in generating a list of cancer-related topics to focus on in their disclosure sessions.
Partners were instructed to keep the focus of the conversation primarily on the patient's
experience, and disclose their own thoughts and feelings only as necessary to facilitate the
patient's disclosure. (This continued primary focus on the patient's thoughts and feelings
distinguishes the intervention for other couple-based interventions such as cognitive-
behavioral couple therapy which places a bilateral focus on both people's thoughts and
feelings shared reciprocally during a conversation24).
In the subsequent three sessions, the therapist first presented a brief review of the strategies
taught in the first session. The patient was then provided with an opportunity to talk about
his/her feelings and concerns about the cancer experience. The couple was instructed that
their goal was for the patient to focus on the expression of his/her feelings and concerns
related to the cancer experience, and for the partner to utilize the skills learned in the initial
session to facilitate disclosure as well as to communicate acceptance and understanding.
During the disclosure, the therapist intervened only as necessary to: (a) discourage negative
interactions, (b) stimulate disclosure using the concern list generated by the patient in the
first session, and (c) ensure that the couple's discussion focused primarily on the patient's
experience rather than the partner's. Couples were encouraged to continue these
conversations on their own outside of sessions, however they were not given specific home
practice assignments.
Cancer Education/Support Couple Condition
In order to hold constant the focus on the couple and cancer during intervention, couples in
the cancer education/support condition also attended four face-to-face sessions. The
therapists and the scheduling of the sessions were the same as that for the partner-assisted
emotional disclosure intervention. The education/support sessions centered on presenting
information relevant to living with cancer and were supplemented with handouts. The
sessions focused on the following topics: Orientation to the cancer center and the treatment
team; suggestions for communicating with health care providers; resources for health
information, psychosocial support, and financial concerns; evaluating health information on
the internet; the impact of cancer on different domains of quality of life; and suggestions for
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maintaining quality of life. Patients and partners in the education/support condition did not
receive any training in communication skills and patients were not encouraged to discuss
their thoughts and feelings related to the cancer experience with their partner.
Uniformity of Treatment
Several steps were taken to ensure that the treatment protocols were uniform and that the
therapists followed the treatment protocols in a uniform manner. These included therapist
training, use of detailed treatment outlines, audiotaping of sessions and therapist
supervision, and assessments of treatment adherence and therapist competence.
Data Analyses
Multilevel modeling for dyadic data40, 41 was used to test group differences over time and
whether these varied for patients versus partners. Multilevel modeling has a number of
advantages over traditional analytic techniques such as repeated measures ANOVA in that it
allows for unbalanced data in terms of number and timing of data points, accommodates
both time-varying and time-invariant covariates, and are able to account for the fact that data
from one member of a couple is influenced by data from the other member of that couple.41
Age, time since diagnosis, and cancer stage were centered and then entered first into the
model as covariates. Main effects included in the model were time (pre versus post),
treatment condition (partner-assisted emotional disclosure versus education/support), and
social role (patient versus partner). Interactions effects included in the model were time X
treatment, and time X treatment X role. A significant intervention effect is indicated by a
significant two-way interaction between treatment (partner-assisted emotional disclosure
versus education/support) and time. A significant three-way interaction (time X treatment X
role) would indicate that the treatment effects were different for patients versus partners.
In order to explore the potential moderating effects of gender and patient holding back as
assessed at baseline, additional models were run including the main and interaction effects
of (a) gender and (b) patient holding back. A significant moderation effect is indicated by a
significant three-way interaction between the moderator (gender or holding back), treatment,
and time, or by a significant four-way interaction (moderator X treatment X time X role).
Data were analyzed first by intent to treat (e.g., including all randomized couples, n=130).
Of these, 108 couples completed post-treatment assessments (see Figure 1). Reasons for
dropout included death/declining health (n=10), not enough time/conflicting demands (n=8),
and loss to contact/not returning to medical center (n=4). A second set of analyses was
conducted including only those couples who attended at least one treatment session (n=53 in
partner-assisted emotional disclosure and n=59 in education/support). The number of
sessions completed by couples in each condition is shown in Figure 1. The reasons for not
completing sessions were similar to those for dropout.
The distribution of relationship quality was negatively skewed. Thus, this variable was log
transformed, and analyses were performed with the log transformed values.
Participant Characteristics
Participant characteristics are presented in Table 1. More than two-thirds of the patients
(71%) were men. Participants were predominantly Caucasian and well-educated. The
majority of patients (64.6%) had Stage 4 disease. On average, couples had been married
23.4 years.
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Results of mixed model dyadic analyses including all participants indicated that there was a
significant time X treatment effect for relationship quality (B=−.07, SE=0.03, p=.02). The
time X treatment effect was not significant for intimacy or mood disturbance. The three way
interactions between time, treatment, and social role (patient versus partner) were also not
significant, indicating that the treatment effect did not differ for patients versus partners for
any of the outcome variables. There were no significant main effects of time indicating that
these variables did not change over time in general. There were also no significant main
effects of social role, indicating that levels of relationship quality, intimacy, and mood
disturbance did not differ significantly between patients and partners.
The significant time X treatment interaction for relationship quality was graphed according
to the strategies recommended by Preacher, Curran, and Bauer42 (see Figure 2). Patients
and spouses in the partner-assisted emotional disclosure condition reported increases in
relationship quality from pre to post relative to patients and spouses in the education/support
condition.
Models including gender as a potential moderator indicated that there were no significant
interactions between gender, treatment condition, and time. However, analyses including
patient holding back indicated significant three-way interactions (holding back X treatment
condition X time) for relationship quality (B=0.10, SE=0.03, p<.0001) and intimacy (B=.56,
SE=0.28, p=.02). As can be seen in Figures 3 and 4, the positive effect of the partner-
assisted emotional disclosure intervention on relationship quality and intimacy occurred
only when patients reported high levels of holding back from talking about cancer-related
concerns to their spouse at baseline.
Treatment completers
The above analyses were repeated, this time including only those couples who had
completed at least one session of the intervention (N=53 in partner-assisted emotional
disclosure, N=59 in education/support). The time X treatment interaction remained
significant for relationship quality (B=−0.08, SE=0.04, p=.02). In addition, there was a
significant three-way interaction between time, treatment, and social role (patient versus
partner) for intimacy (B=−0.60, SE=0.30, p=.05). There were no main or interaction effects
for mood disturbance.
The significant time X treatment X role interaction for intimacy was graphed according to
the strategies recommended by Preacher, Curran, and Bauer. 42 As can be seen Figure 5, a
positive effect of partner-assisted emotional disclosure on intimacy was seen among patients
but not partners. However, in models containing patient baseline holding back, the three-
way interaction between holding back, treatment condition, and time continued to be
significant for both relationship quality and intimacy; the four-way interaction (holding back
X treatment condition X time X role) was not significant. This suggests that both patients
and partners experienced improvements in relationship quality and intimacy following the
partner-assisted emotional disclosure intervention if the patient initially reported high levels
of holding back. Models including gender as a potential moderator indicated that there were
no significant interactions between gender, treatment condition, and time.
Discussion
Findings from this study suggest that a brief, couple-based intervention that specifically
targeted communication of cancer-related thoughts and feelings in patients with GI cancer
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led to improvements in relationship quality and intimacy for couples in which the patient
initially reported higher levels of holding back from discussing cancer-related concerns.
This finding is noteworthy in light of the brevity of the intervention, the length of marriage
among couples in the study (mean=24 years), and the severity of the patient's illness (two-
thirds of the patients were diagnosed with Stage 4 cancer). Improving the quality of the
couple relationship is particularly important in this population due to their shortened life
expectancy and the vital role that spouses play in patients' care at the end of life. This study
had a number of methodological strengths including comparing the partner-assisted
emotional disclosure intervention to a couples cancer education/support condition that
controlled for time and attention given to the patients and partners, and the use of
sophisticated data analytic techniques (e.g., multilevel models) that are uniquely suited to
analyzing data from couple-based interventions.40, 41
“Holding back” likely reflects patients' active inhibition of disclosing their cancer-related
concerns with their partners rather than a general tendency towards inexpression. Thus,
patients who report high levels of holding back may want to discuss these concerns but may
be reluctant to do so. It is interesting to note that, on average, patient's levels of holding back
as assessed at baseline were quite low (mean=0.82, SD=0.99, range=0–4). Thus, even
patients considered “high” in holding back did not indicate that they held back from
discussing their cancer-related concerns with their spouse to a large degree. These levels of
holding back are similar to what we found in a previous study with the same patient
population.16 However, even this relatively modest degree of holding back was associated
with significantly poorer individual and relationship functioning.16 Results from this study
suggest that helping patients to overcome their reluctance to express their concerns may lead
to significant improvements in the quality of their marital relationships and in the amount of
intimacy they share with their spouse. This is consistent with research indicating that
disclosure of personal, vulnerable information is a central component of intimacy13, 14
which is in turn closely linked to relationship satisfaction.27
Contrary to our hypotheses as well as to the literature on private emotional disclosure, the
intervention did not lead to improvements in psychological distress among patients or
partners. One possible explanation for this lack of findings is that, although the intervention
was designed to facilitate patient disclosure, patients may have been unable to disclose their
thoughts and feelings to their partner (and in the presence of a therapist) to the extent that
they would have in a private disclosure protocol. Some patients may have felt inhibited
about sharing their thoughts and feelings with their partner and/or the therapist.
Alternatively, the sessions' dual focus on both the patient's disclosure and on the dyad's
communication processes may have distracted the patient from expressing and processing
their thoughts and feelings to the same extent that they would have in a private disclosure
protocol. Another possibility is that patients may have felt that their disclosure was
burdensome to their partners, and that this sense of burden off-set any psychological benefits
of disclosure. Importantly, however, there was no evidence that the partner-assisted
emotional disclosure sessions led to increased psychological distress for patients or partners.
Finally, it is possible that the effects of the intervention were dampened by the fact the many
couples did not receive all four sessions. Future studies of partner-assisted emotional
disclosure should consider strategies to increase retention in the intervention, such as
offering home-based sessions or targeting patients with less advanced disease. It may also be
necessary to increase the number of sessions so that patients become more comfortable with
the setting and the communication guidelines and have more opportunity to disclose. In
addition, future studies should explore the possibility that the two formats of disclosure –
partner-assisted versus private – have different effects. Partner-assisted protocols in which
patients disclose their concerns to their partner may be more effective in enhancing couples'
relationships, whereas private disclosure protocols in which patients write about their
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thoughts and feelings may be more effective in reducing patient's psychological distress. If
so, then treatment can be targeted according to the specific needs of the patient and the
couple.
Due to the focus of the intervention on patient disclosure, it is perhaps less surprising that
partners did not benefit in terms of reduced psychological distress. While many partners
expressed appreciation for the opportunity to hear the patient discuss his/her concerns, it was
also at times difficult for them to listen to the patient describe painful experiences and
emotions, particularly because partners were asked to refrain from reassuring the patient or
giving advice or suggestions. Thus, any benefits for partners may have been off-set by
increased burden from listening to the patient's concerns. However, as noted above, partners
did not experience increases in distress as a result of the partner-assisted emotional
disclosure intervention. Given the high burden of cancer caregiving43, 44, particularly when
the patient has advanced disease45, 46, particular attention should be given to developing
interventions that may help alleviate partner distress. Enhancing cancer-related
communication between partners may ultimately benefit both patients and partners if it leads
to increased relationship functioning and a shared understanding about the meaning of the
illness experience. One interesting direction for future research would be to explore the
relative benefits for patients and partners of including a more reciprocal approach to
disclosure (e.g. partners disclosing to patients as well as patients to partners). In addition,
longer-term effects of the partner-assisted emotional disclosure intervention should be
examined as it is possible that short-term improvements in relationship satisfaction could
potentially lead to improvements in individual psychological well-being for patients and/or
partners.
These findings build on the literature on private emotional disclosure which has found that
writing about cancer concerns can lead to benefits for patients with cancer17–19. To our
knowledge, this is the first study of cancer patients that has applied a disclosure paradigm in
the context of a patient disclosing to their spouse or intimate partner. There are several
reasons that partner-assisted disclosure is particularly appropriate for cancer patients and
their partners. The diagnosis and treatment of most cancers places major demands not only
on patients but their partners as well. Although patients and partners must work together to
meet these demands, communication particularly about emotionally related topics can be
challenging even in relationships that overall are strong. The results of the current study are
promising in showing that a brief intervention targeting patient disclosure to their partner
can be beneficial for couples' relationships. Future studies are needed to replicate these
findings in patients and partners who are coping with other types of cancer (e.g. breast
cancer, prostate cancer, or lung cancer).
From a clinical perspective, the findings of this study suggest that psychologists, social
workers, and other mental health professionals working with GI cancer patients may want to
identify patients who tend to hold back from expressing their cancer-related thoughts and
feelings to their partners, and work with them and their partners to help facilitate
communication. In the current study, the only demographic or medical variable associated
with holding back was age, indicating that younger patients were more likely to hold back.
This is consistent with clinical impressions that younger patients often have more difficulty
coping cancer. Overall, despite the fact that most couples reported having strong
relationships at baseline, many commented on the fact that the treatment sessions were
helpful in enhancing their relationship further in that they gave them the opportunity to
discuss important issues that they had previously avoided. Similar to what has been reported
in previous studies,6–8 patients often noted that their biggest need was for someone to listen
to them, and that it was helpful to be able to express their concerns more openly to their
partner. Partners, on the other hand, often found it difficult not to respond to the patient's
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concerns with reassurance or problem-solving, but over the course of the sessions learned to
appreciate that validating the patient's concerns was more helpful to the patient and also
resulted in a higher degree of patient disclosure.
Several limitations need to be kept in mind when interpreting the results of this study. First,
the participation rate in this study (25%) is somewhat lower than that obtained in other
recent couple-based or caregiver-assisted studies with cancer patients (range= 34% 47, 48 to
43%49), possibly due to the fact that many of the patients approached about participation
were quite ill. Patient illness was a significant factor in attrition as well. Recruitment and
retention were also likely hampered by the fact that participation required that couples attend
four, face-to-face sessions. Future studies could test the efficacy of telephone- or internet-
based interventions that could be made available to a wider population of couples. A second
limitation is that the couples who participated in this study on average reported high levels
of relationship quality. The findings may not generalize to couples who are more distressed
who quite likely need a more lengthy and intensive intervention. Third, the results of the
study likely reflect the sample of patients who participated who tended to be well-educated
and have advanced disease. The gender composition of the sample (more male than female
patients), may have also influenced the pattern of results. Women have been found to self-
disclose more than men, although this difference diminishes in the context of heterosexual
relationships14, 50 and was not evident from the baseline data of the current study. Gender
differences in response to written emotional disclosure interventions have also been found.
22 Thus, it is possible that the results would not generalize to samples of female patients, or
to contexts other than heterosexual romantic relationships
Taken together, the results of this study suggest that future research on partner-assisted
emotional disclosure is warranted. This is a novel intervention that builds on both the private
emotional disclosure and the cognitive-behavioral marital therapy literature. While the
benefits in the current study were reflected primarily in indices of the quality of the couple's
relationship, it is possible that these short-term improvements in relationship quality and
intimacy could be associated with longer-term improvements in both patient and partner
individual functioning. In addition to examining longer-term effects, future research could
also explore methods of enhancing the effects of the intervention, such as using a mixture of
lab-based and home-based partner-assisted disclosure sessions, increasing the number of
sessions, and/or exploring the relative benefits of having partners disclose to patients as well
as patients to partners. In addition, future research needs to focus on more distressed couples
for whom more intensive approaches are likely necessary. Given the important role that
partners play in patients' adaptation to cancer, it is critical to help patients and partners
communicate effectively about their cancer-related concerns.
Condensed Abstract
Partner-assisted emotional disclosure is a brief intervention focused on facilitating the
cancer patient's emotional disclosure to his/her partner. Results from this study suggest
that this intervention led to increases in relationship quality and intimacy for couples in
which the patient initially held back from disclosing cancer-related concerns.
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Estimated trajectories of change in patients' and partners' scores (logged values) on the
Quality of Marriage Index by treatment condition (intent to treat analysis).
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Estimated trajectories of change in patients' and partners' scores (logged values) on the
Quality of Marriage Index by treatment condition and patient baseline holding back (intent
to treat analysis).
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Estimated trajectories of change in patients' and partners' scores Miller Social Intimacy
Scale by treatment condition and patient baseline holding back (intent to treat analysis).
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Estimated trajectories of change in scores on the Miller Social Intimacy Scale by social role
(patient versus partner) and treatment condition (treatment completer analysis).
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Table 1
Participant characteristics
Patients (N=130) Partners (N=130)
Mean age (SD) 59.4 (12.0) 59.3 (12.3)
Gender (% male) 71 29
Race
 Caucasian 84.5% 82.0%
 African American 11.6% 11.2%
 Other/unknown 3.9% 6.4%
Education
 <12 years 14.2% 8.2%
 High school graduate 30.9% 32.3%
 Some college 29.6% 30.2%
 College graduate/post-graduate 25.3% 29.3%







 2 n=16 (12.3%)
 3 n=30 (23.1%)
 4 n=84 (64.6%)
Cancer treatments at baseline
 Chemotherapy n=79 (60.8%)
 Radiation n=11 (8.5%)
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